Magellan LongevityReviews podcast › PARP
M
Magellan Longevity Reviews

PARP — research review 2

A short, evidence-grounded conversation about PARP and its place in longevity science.

Speaker 1
…and that brings us to PARP, another molecule generating a lot of buzz in the longevity space. We’re talking about Poly-ADP-Ribose Polymerase.
Speaker 2
Right, and specifically, its role as an NAD⁺-dependent DNA-repair enzyme. It’s critical for maintaining genome stability, which is, of course, a hallmark of aging.
Speaker 1
Exactly. PARP enzymes essentially detect and repair DNA damage. But here's the interesting part: they consume NAD⁺ in the process. This means PARP activity competes with sirtuins, another set of important longevity-related enzymes, for the same pool of NAD⁺.
Speaker 2
So, if PARP is highly active repairing DNA damage, it could potentially reduce NAD⁺ availability for sirtuins, which also require NAD⁺ to function. That’s the theoretical connection researchers are exploring.
Speaker 1
Exactly. The idea is that modulating PARP activity, perhaps by inhibiting it, could preserve NAD⁺ for sirtuins and potentially impact aging pathways. But what does the human evidence actually show?
Speaker 2
This is where we need to be careful. While there’s compelling preclinical data, human clinical trials specifically targeting PARP modulation for healthy aging are still quite limited. Many studies on PARP inhibitors are in oncology, focused on cancer treatment due to their role in DNA repair, like the findings in Lancet Oncology in 2021.
Speaker 1
Which is a very different context. For healthy human longevity, we currently don't have large, long-term randomized controlled trials showing direct benefits from PARP modulation. The optimal level of PARP activity for healthy aging in humans, or even if modulating it provides a net positive effect, remains largely unknown.
Speaker 2
So, while the biology is fascinating, the human evidence for PARP modulation as a longevity intervention is still primarily theoretical. We need to see those clinical trials.
Read the PARP monograph → Explore the Pathway Universe  🌌 ← All episodes

Educational research discussion only — not medical advice. Statements have not been evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to a qualified clinician before changing any treatment.